Treace Medical Concepts Past Earnings Performance
Past criteria checks 0/6
Treace Medical Concepts's earnings have been declining at an average annual rate of -43.5%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 30.8% per year.
Key information
-43.5%
Earnings growth rate
-37.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 30.8% |
| Return on equity | -58.6% |
| Net Margin | -30.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Further Upside For Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Could Introduce Price Risks After 84% Bounce
Dec 03
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?
Oct 26Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch
Aug 02Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?
Jun 28Treace Medical Concepts: Facing Increasing Competitive Pressure
Jun 14Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Apr 05Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?
Feb 09Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge
Jan 04Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower
Nov 11Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results
Aug 13Revenue & Expenses Breakdown
How Treace Medical Concepts makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 203 | -62 | 206 | 19 |
| 30 Jun 24 | 199 | -64 | 206 | 19 |
| 31 Mar 24 | 196 | -55 | 198 | 17 |
| 31 Dec 23 | 187 | -50 | 188 | 15 |
| 30 Sep 23 | 175 | -48 | 175 | 15 |
| 30 Jun 23 | 167 | -42 | 163 | 14 |
| 31 Mar 23 | 155 | -47 | 153 | 14 |
| 31 Dec 22 | 142 | -43 | 138 | 14 |
| 30 Sep 22 | 126 | -45 | 126 | 13 |
| 30 Jun 22 | 114 | -39 | 112 | 12 |
| 31 Mar 22 | 105 | -27 | 97 | 11 |
| 31 Dec 21 | 94 | -21 | 84 | 10 |
| 30 Sep 21 | 85 | -12 | 67 | 9 |
| 30 Jun 21 | 78 | -8 | 57 | 8 |
| 31 Mar 21 | 65 | -5 | 44 | 6 |
| 31 Dec 20 | 57 | -4 | 38 | 6 |
| 31 Dec 19 | 39 | -5 | 30 | 5 |
Quality Earnings: TMCI is currently unprofitable.
Growing Profit Margin: TMCI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TMCI is unprofitable, and losses have increased over the past 5 years at a rate of 43.5% per year.
Accelerating Growth: Unable to compare TMCI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TMCI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (15%).
Return on Equity
High ROE: TMCI has a negative Return on Equity (-58.65%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 03:40 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Treace Medical Concepts, Inc. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Gorman | BTIG |
| Robert Marcus | J.P. Morgan |
| Benjamin Haynor | Lake Street Capital Markets, LLC |